NCT01078844终止不适用
Memantine in Adult Autism Spectrum Disorder
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Clinical Global Impression-Scale(CGI-S)
研究概览
简要总结
The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Placebo
Placebo Comparator
Treatment as usual plus placebo
干预措施: Placebo (Drug)
memantine
Active Comparator
Treatment as usual plus memantine
干预措施: memantine (Drug)
结局指标
主要结局
Clinical Global Impression-Scale(CGI-S)
时间窗: 12 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
早期 1 期
Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance SpectroscopyAutism Spectrum DisorderNCT02811627University of Missouri-Columbia10
Unknown
4 期
Memantine Treatment in Alzheimer's Disease PatientsAlzheimer DiseaseNCT03168997Wei Cuibai222
已完成
3 期
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismAutismNCT00498173Massachusetts General Hospital60
已完成
不适用
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderAutistic DisorderAsperger SyndromeAutism Spectrum DisorderPervasive Developmental DisorderNCT03170453University of Pittsburgh86
已完成
不适用
Cognitive Enhancement Therapy for Adult Autism Spectrum DisorderAutistic DisorderAutism Spectrum DisorderPervasive Developmental DisorderAsperger's SyndromeNCT00902798University of Pittsburgh54